SEC treatment lowered the expression of anti-apoptotic proteins Bcl-2 and Bcl-xL but upregulated the expression of pro-apoptotic protein Bax in both CRC cells (Figure 3D). This evidence concerns the gene BCL2 and colorectal carcinoma.